Recently, Suzhou Borui Sunga Medical Technology Co., Ltd., a holding subsidiary of Suzhou Elite Technology Co., Ltd., has successfully reached a sales cooperation with Armada MedTech, an Indonesian customer. The order includes one set of CM-C1 Automatic Glycated Hemoglobin Analyzer, together with a number of supporting kits, quality control products and calibrators, marking the further expansion of domestic medical equipment in the Southeast Asian market.
The CM-C1 Automatic Glycated Hemoglobin Analyzer delivers superior performance, with repeatability and anti-interference capability meeting international mainstream standards. It has obtained dual certifications from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the National Glycohemoglobin Standardization Program (NGSP) of the United States, providing reliable support for clinical testing.
Headquartered in Singapore, Armada MedTech has a core team composed of senior professionals with more than 10 years of experience in the healthcare industry and investment. Leveraging the advantages of China's medical industry supply chain, the company focuses on in vitro diagnostics, life sciences, innovative medical technologies and other fields, providing global customers with cost-effective R&D, production, sales and service support. In this cooperation, the Indonesian customer will replace imported instruments with this device, further highlighting the core competitiveness of domestic medical products.
In the future, Elite will continue to join hands with Southeast Asian partners to expand the market, promote domestic medical products and services to countries along the "Belt and Road", and help improve local medical testing capabilities. As a China-based "excellent and specialized" overall solution provider of chromatography technology, the company will always take technological innovation as the core and create more value for the cause of human health.
